Re (RMAX) EBITDA (2012 - 2026)

Re (RMAX) has 15 years of EBITDA data on file, last reported at -$7.2 million in Q1 2026.

• EBITDA for Q1 2026 came in at -$7.2 million, down 221.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.3 million (down 16.52% YoY), and the FY2025 annual result was $49.4 million, up 16.12% from the prior year.
• EBITDA declined to -$7.2 million in Q1 2026 per RMAX's latest filing, from $9.9 million in the prior quarter.
• Over five years, EBITDA peaked at $18.9 million in Q3 2025 and troughed at -$21.0 million in Q3 2023.
• A 5-year average of $6.6 million and a median of $7.6 million in 2022 frame the typical range for EBITDA.
• The sharpest annual moves came in 2023 and 2024: EBITDA plunged 501.11% in 2023, then surged 175.3% in 2024.
• A 5-year view of EBITDA shows it stood at $8.5 million in 2022, then plunged by 214.58% to -$9.7 million in 2023, then jumped by 150.22% to $4.9 million in 2024, then jumped by 103.61% to $9.9 million in 2025, then plunged by 172.84% to -$7.2 million in 2026.
• Business Quant data shows RMAX's EBITDA at -$7.2 million in Q1 2026, $9.9 million in Q4 2025, and $18.9 million in Q3 2025.